Cellbxhealth PLC
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ANPCF research report →
About the company
CelLBxHealth plc, formerly known as ANGLE plc until its name change in October 2025, is a medical diagnostics enterprise established in 1994 and headquartered in Guildford, United Kingdom. The company is dedicated to developing advanced cancer diagnostic products, serving markets across the United Kingdom, Europe, North America, and other international regions. Its core offerings include the Parsortix PC1 and PR1 systems, which are innovative medical devices engineered to capture and retrieve intact circulating tumor cells (CTCs) from patient blood.
- CEO
- Peter Michael Collins
- IPO
- 2014
- Employees
- 119
- HQ
- Guildford, GB
Price Chart
- Revenue
- $1.35M · -52.80%
- Net Income
- $-19,505,838 · -37.12%
- EPS
- $-0.06 · -14.32%
- Op Income
- $-20,201,725
- FCF YoY
- 32.68%
- 52W High
- $0.11
- 52W Low
- $0.01
- 50D MA
- $0.02
- 200D MA
- $0.02
- Beta
- 0.43
- Avg Volume
- 488
Get TickerSpark's AI analysis on ANPCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ANPCF coverage
Recent articles, reports, and earnings notes.
No research on ANPCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ANPCF report →Similar companies
Peers in the same neighborhood.